{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T18:00:23Z","timestamp":1757700023236,"version":"3.40.3"},"publisher-location":"Boston, MA","reference-count":35,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781461371335"},{"type":"electronic","value":"9781461547099"}],"license":[{"start":{"date-parts":[[1999,1,1]],"date-time":"1999-01-01T00:00:00Z","timestamp":915148800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1999]]},"DOI":"10.1007\/978-1-4615-4709-9_13","type":"book-chapter","created":{"date-parts":[[2011,9,15]],"date-time":"2011-09-15T23:01:40Z","timestamp":1316127700000},"page":"95-100","source":"Crossref","is-referenced-by-count":7,"title":["The Serotonergic Appetite Suppressant Fenfluramine"],"prefix":"10.1007","author":[{"given":"G.","family":"Curzon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. L.","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"13_CR1","first-page":"403","volume-title":"Amino Acids in Health and Disease: New Perspectives","author":"JE Blundell","year":"1987","unstructured":"Blundell, J.E. and Hill, A.J., 1987, Influence of tryptophane on appetite and food selection in man. In: Amino Acids in Health and Disease: New Perspectives, Kaufman, S., ed., Alan R. Liss, New York, p. 403\u2013419."},{"key":"13_CR2","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S0031-6989(82)80025-8","volume":"14","author":"E Borsini","year":"1982","unstructured":"Borsini, E, Bendotti, L., Aleotti, A., Samanin, R., and Garattini, S., 1982 d-Fenfluramine and d-norfenfluramine reduce food intake by acting on different serotonin mechanisms in the rat brain, Pharmacol. Res. Comm. 14:671\u2013678.","journal-title":"Pharmacol. Res. Comm."},{"key":"13_CR3","first-page":"65","volume-title":"Obesity Management and Redux\u2122","author":"B Campbell","year":"1997","unstructured":"Campbell, B., Dard-Brunelle, B., and Caccia, S., 1997, The use of pharmacokinetics in the assessment of dexfenfluramine safety. In: Obesity Management and Redux\u2122, Nicolaidis, S. ed. Academic Press, San Diego, p. 65\u201380."},{"key":"13_CR4","first-page":"684","volume":"39","author":"G Cheymol","year":"1995","unstructured":"Cheymol, G., Weissenburger, J., Poirier, J.M., and Gellee, C., 1995, The pharmacokinetics of dexfenfluramine in obese and non-obese subjects, Br. J. Clin. Pharmacol. 39:684\u2013687.","journal-title":"Br. J. Clin. Pharmacol."},{"key":"13_CR5","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S0022-3565(24)37252-0","volume":"284","author":"P Clausing","year":"1998","unstructured":"Clausing, P., Newport, G.D. and Bowyer, J.F., 1998, Fenfluramine and norfenfluramine levels in brain microdialysate brain tissue and plasma of rats administered doses of d-fenfluramine known to deplete 5-hydroxytryptamine levels in brain, J. Pharmacol. Exp. Ther. 284:618\u2013624.","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"13_CR6","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1056\/NEJM199708283370901","volume":"337","author":"HM Connolly","year":"1997","unstructured":"Connolly, H.M., Crary, J.L., McGoon, M.D., Hensrud, D.D., Edwards, B.S., Edwards, W.D., and Schaff, H.V., 1997, Valvular heart disease associated with phenfluramine phentermine, N. Engl. J. Med. 337:581\u2013588.","journal-title":"N. Engl. J. Med."},{"key":"13_CR7","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1038\/sj.bjp.0701509","volume":"122","author":"J Cortijo","year":"1997","unstructured":"Cortijo, J., Marti-Cabrera, M., Bernabeu, E., Domenech, T., Bou, J., Fernandez, A.G., Beleta, J.M., Palacios, J.M., and Morcillo, E.J., 1997, Characterization of 5-HT receptors in human pulmonary artery and vein: functional and binding studies, Br. J. Pharmacol. 122:1455\u20131463.","journal-title":"Br. J. Pharmacol."},{"key":"13_CR8","first-page":"43","volume-title":"Serotonin in the central Nervous System and Periphery","author":"G Curzon","year":"1995","unstructured":"Curzon, G., 1995, Serotonergic aspects of feeding, In: Serotonin in the central Nervous System and Periphery, Takada A. and Curzon G., eds., Elsevier Amsterdam pp. 43\u201351."},{"key":"13_CR9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0165-6147(96)01003-6","volume":"18","author":"G Curzon","year":"1997","unstructured":"Curzon, G., Gibson, E.L., and Oluyomi, A.O., 1997, Appetite suppression by commonly used drugs depends on 5-HT receptors but not on 5-HT availability. Trends Pharmacol. Sci. 18:21\u201325.","journal-title":"Trends Pharmacol. Sci."},{"key":"13_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0014-2999(97)01124-2","volume":"333","author":"KP Datla","year":"1997","unstructured":"Datla, K.P. and Curzon, G., 1997, The effect of D-fenfluramine on brain 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in male and female rats, Eur. J. Pharmacol. 333:27\u201331.","journal-title":"Eur. J. Pharmacol."},{"key":"13_CR11","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/0014-2999(93)90013-8","volume":"242","author":"EL Gibson","year":"1993","unstructured":"Gibson, E.L., Kennedy, A.J., and Curzon, G., 1993, d-Fenfluramine and d-norfenfluramine induced hypophagia: differential mechanisms and involvement of postsynaptic 5-HT receptors, Eur. J. Pharmacol. 242:83\u201390.","journal-title":"Eur. J. Pharmacol."},{"key":"13_CR12","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1056\/NEJM199708283370911","volume":"337","author":"DJ Graham","year":"1997","unstructured":"Graham, D.J. and Green, L., 1997, Further cases of valvular heart disease associated with fenfluramine\u2014phentermine, N. Engl. J. Med. 337:635.","journal-title":"N. Engl. J. Med."},{"key":"13_CR13","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/0014-2999(94)00766-Z","volume":"274","author":"S Grignaschi","year":"1995","unstructured":"Grignaschi, S., Sironi, F., and Samanin, R., 1995, The 5-HT1B receptor mediates the effect of d-fenfluramine on eating caused by intra-hypothalamic injection of neuropeptide Y., Eur. J. Pharmacol. 274:221\u2013224.","journal-title":"Eur. J. Pharmacol."},{"key":"13_CR14","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/S0140-6736(89)91499-2","volume":"2","author":"B Guy-Grand","year":"1989","unstructured":"Guy-Grand, B., Apfelbaum, M., Crepaldi, G., Griess, A., Lefebvre, P., and Turner, P., 1989, International trial of long term dexfenfluramine in obesity, Lancet 2:1142\u20131144.","journal-title":"Lancet"},{"key":"13_CR15","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/0031-9384(96)00073-X","volume":"60","author":"JCG Halford","year":"1996","unstructured":"Halford, J.C,G. and Blundell, J.E., 1996, The 5-HT1B receptor agonist CP-94,153 reduces food intake and preserves the behavioural satiety sequence, Physiol. Behav. 60:933\u2013939.","journal-title":"Physiol. Behav."},{"key":"13_CR16","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0002-9343(99)80156-9","volume":"99","author":"P Herv\u00e9","year":"1995","unstructured":"Herv\u00e9, P., Launay, J.M., Scrobohaci, M.L., Brenot, F., Simonneau, G., Petitpretz, P., Poubeau, P., Cerrina, J., Duroux, P., and Drouet, L., 1995, Increased plasma serotonin in primary pulmonary hypertension, Am. J. Med. 99:249\u2013254.","journal-title":"Am. J. Med."},{"key":"13_CR17","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/0014-2999(87)90561-9","volume":"141","author":"GA Kennett","year":"1987","unstructured":"Kennett, G.A., Dourish, C.T., and Curzon, G., 1987, 5HT1B agonists induce anorexia at a postsynaptic site, Eur.J. Pharmacol. 141:429\u2013435.","journal-title":"Eur.J. Pharmacol."},{"key":"13_CR18","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1152\/physrev.1994.74.4.761","volume":"74","author":"AH Kissebah","year":"1994","unstructured":"Kissebah, A.H. and Krakower, G.R., 1994, Regional adiposity and morbidity, Physiol. Rev. 74:761\u2013811.","journal-title":"Physiol. Rev."},{"issue":"Suppl 1","key":"13_CR19","first-page":"S51","volume":"11","author":"SF Leibowitz","year":"1988","unstructured":"Leibowitz, S.F., Weiss, G. F., and Shor-Posner, G., 1988, Hypothalamic serotonin: pharmacological, biochemical and behavioural analyses of its feeding\u2014suppressive action, Clin. Neuropharmacol. 11Suppl 1: S51\u2013S71.","journal-title":"Clin. Neuropharmacol."},{"key":"13_CR20","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/(SICI)1098-2396(199705)26:1<36::AID-SYN4>3.0.CO;2-F","volume":"26","author":"R Lew","year":"1997","unstructured":"Lew, R., Weisenberg, B., Vosmer, G., and Seiden, L.S., 1997, Combined phentermine\/fenfluramine administration enhances depletion of serotonin from central terminal fields, Synapse 26:36\u201345.","journal-title":"Synapse"},{"key":"13_CR21","doi-asserted-by":"crossref","first-page":"5537","DOI":"10.1523\/JNEUROSCI.18-14-05537.1998","volume":"18","author":"JJ Lucas","year":"1998","unstructured":"Lucas, J.J., Yamamoto, A., Scearce-Levie, K., Saudou, F., and Hen, R., 1998, Absence of fenfluramine-induced anorexia and reduced C-fos induction in the hypothalamus and central amygdaloid complex of serotonin 1B knock-out mice, J. Neurosci. 18:5537\u20135544.","journal-title":"J. Neurosci."},{"key":"13_CR22","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/S0011-393X(96)80071-3","volume":"57","author":"TC Marbury","year":"1996","unstructured":"Marbury, T.C., Angelo, J.E., Gulley, R.M., Krosnick, A., Sugimoto, D.H., and Zellner, S.R., 1996, A placebo-controlled, dose-response study of dexfluramine in the treatment of these patients, Curr. Then Res. 57:663\u2013674.","journal-title":"Curr. Then Res."},{"key":"13_CR23","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1001\/jama.1997.03550080076043","volume":"278","author":"UD McCann","year":"1997","unstructured":"McCann, U.D., Seiden, L.S., Rubin, L.J., and Ricaurte, G.A., 1997, Brain serotonin neurotoxicity and primary pulmonary hypertension from fenfluramine and dexfenfluramine. A systematic review of the evidence, JAMA 278:666\u2013672.","journal-title":"JAMA"},{"key":"13_CR24","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/BF00169550","volume":"343","author":"T Mennini","year":"1991","unstructured":"Mennini, T., Bizzi, A., Caccia, S., Codegoni, A., Fracasso, L., Fritolli, E., Guiso, G., Padura, I.M., Taddei, C., Uslenghi, A., and Garatinni, S., 1991, Comparative studies on the anorectic activity of d-fenfluramine in mice, rats, and guinea pigs, Naunyn-Schmiedeberg\u2019s Arch. Pharmacol. 343:483\u2013490.","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"13_CR25","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1001\/jama.1996.03540230057036","volume":"276","author":"National Task Force on the Prevention and Treatment of Obesity","year":"1996","unstructured":"National Task Force on the Prevention and Treatment of Obesity, 1996, Long-term pharmacotherapy in the management of obesity, JAMA., 276:1907\u20131915.","journal-title":"JAMA."},{"key":"13_CR26","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/BF00442252","volume":"97","author":"JC Neill","year":"1989","unstructured":"Neill, J.C. and Cooper, S.J., 1989, Evidence that d-fenfluramine anorexia is mediated by 5-HT1 receptors, Psychopharmacology 97:213\u2013218.","journal-title":"Psychopharmacology"},{"key":"13_CR27","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/0014-2999(94)90646-7","volume":"264","author":"AO Oluyomi","year":"1994","unstructured":"Oluyomi, A.O., Gibson, E.L., Barnfield, A.M.C., and Curzon, G., 1994a, d-Fenfluramine and d-norfenfluramine hypophagias do not require increased hypothalamic 5-hydroxytryptamine release, Eur. J. Pharmacol. 264:111\u2013115.","journal-title":"Eur. J. Pharmacol."},{"key":"13_CR28","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/0014-2999(94)90096-5","volume":"255","author":"AO Oluyomi","year":"1994","unstructured":"Oluyomi, A.O., Datla, K.P., and Curzon, G., 1994b, Effects of d-fenfluramine on feeding and hypothalamic 5-hydroxytryptamine and dopamine in male and female rats, Eur. J. Pharmacol. 255:175\u2013183.","journal-title":"Eur. J. Pharmacol."},{"key":"13_CR29","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0022-3565(25)09524-2","volume":"273","author":"M Raiteri","year":"1995","unstructured":"Raiteri, M., Bonanno, G., and Vallebuona, F., 1995, In vitro and in vivo effects of d-fenfluramine: no apparent relation between 5-hydroxytryptamine release and hypophagia, J. Pharm. Exp. Ther. 273:643\u2013649.","journal-title":"J. Pharm. Exp. Ther."},{"key":"13_CR30","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/0014-2999(91)90366-X","volume":"197","author":"R Samanin","year":"1991","unstructured":"Samanin, R., Neill, K.C., Grignaschi, G. Padura, I.M., Bizzi, A., and Garattini, S., 1991, Role of 5-HT receptors in the effect of d-fenfluramine on gastric emptying and feeding behaviour as examined in the running test, Eur. J. Pharmacol. 197:69\u201373.","journal-title":"Eur. J. Pharmacol."},{"key":"13_CR31","first-page":"83","volume-title":"Obesity Management and Redux\u2122","author":"BW Sandage","year":"1997","unstructured":"Sandage, B.W., 1997, Overview of the clinical data. In: Obesity Management and Redux\u2122, Nicolaidis, S., ed. Academic Press, San Diego, p. 83\u201386."},{"key":"13_CR32","first-page":"195","volume":"5","author":"JT Snow","year":"1986","unstructured":"Snow, J.T. and Harris, M.B., 1986, An analysis of weight and diet content in five women\u2019s interest magazines, J. Obes. Weight Regul. 5:195\u2013214.","journal-title":"J. Obes. Weight Regul."},{"key":"13_CR33","volume-title":"Obesity: preventing and managing the global epidemic","author":"W.H.O.","year":"1998","unstructured":"W.H.O., 1998, Obesity: preventing and managing the global epidemic, W.H.O., Geneva."},{"key":"13_CR34","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/0031-9384(88)90100-X","volume":"43","author":"PJ White","year":"1988","unstructured":"White, P.J., Cybulski, K.A., Primus, R., Johnson, D.F., Collier, G.H., and Wagner, G.L., 1988, Changes in macronutrient selection as a function of dietary tryptophan, Physiol. Behav. 43:73\u201377.","journal-title":"Physiol. Behav."},{"key":"13_CR35","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/1098-108X(199201)11:1<85::AID-EAT2260110112>3.0.CO;2-T","volume":"11","author":"CV Wiseman","year":"1992","unstructured":"Wiseman, C.V., Gray, J.J., Mosimann, J.E., and Ahrens, A.H., 1992, Cultural expectations of thiness in women: an update, Int. J. Eating Disord. 11:85\u201389.","journal-title":"Int. J. Eating Disord."}],"container-title":["Advances in Experimental Medicine and Biology","Tryptophan, Serotonin, and Melatonin"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4615-4709-9_13","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T07:28:47Z","timestamp":1741678127000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4615-4709-9_13"}},"subtitle":["Reappraisal and Rejection"],"short-title":[],"issued":{"date-parts":[[1999]]},"ISBN":["9781461371335","9781461547099"],"references-count":35,"URL":"https:\/\/doi.org\/10.1007\/978-1-4615-4709-9_13","relation":{},"ISSN":["0065-2598"],"issn-type":[{"type":"print","value":"0065-2598"}],"subject":[],"published":{"date-parts":[[1999]]}}}